Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Annals of Surgery|August 7, 2024
The Impact of Low Workplace Support During Pregnancy on Surgeon Distress and Career DissatisfactionThinzar M Lwin, Manuel Castillo-Angeles, Carrie E Cunningham, et al.
Surgery|August 4, 2022
Proof of concept of improved fluorescence-guided surgery of colon cancer liver metastasis using color-coded imaging of a tumor-labeling fluorescent antibody and indocyanine green restricted to the adjacent liver segmentHiroto Nishino, Michael A Turner, Siamak Amirfakhri, et al.
Tissue & Cell|June 15, 2023
Colon-cancer liver metastasis is effectively targeted by recombinant methioninase (rMETase) in an orthotopic mouse modelKentaro Miyake, Qinghong Han, Takashi Murakami, et al.
Oncotarget|May 25, 2017
MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX)Kei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
The Journal of Surgical Research|October 15, 2023
Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse ModelsKristin E Cox, Michael A Turner, Siamak Amirfakhri, et al.
Annals of Surgical Oncology|June 18, 2024
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA AntibodyKristin E Cox, Michael A Turner, Thinzar M Lwin, et al.
Molecular Imaging and Biology|June 21, 2023
Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal CancerThinzar M Lwin, Megan Minnix, Lin Li, et al.
In Vivo (Athens, Greece)|January 1, 2022
Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic XenograftMichael A Turner, Hannah M Hollandsworth, Hiroto Nishino, et al.
American Journal of Surgery|June 17, 2022
Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applicationsMichael A Turner, Hannah M Hollandsworth, Siamak Amirfakhri, et al.
Cell Cycle (Georgetown, Tex.)|April 7, 2018
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancerKei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Pageof 6